| __timestamp | AstraZeneca PLC | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5579000000 | 5280000 |
| Thursday, January 1, 2015 | 5997000000 | 7148000 |
| Friday, January 1, 2016 | 5890000000 | 19594000 |
| Sunday, January 1, 2017 | 5757000000 | 22894000 |
| Monday, January 1, 2018 | 5932000000 | 50337000 |
| Tuesday, January 1, 2019 | 5958000000 | 109450000 |
| Wednesday, January 1, 2020 | 5991000000 | 90450000 |
| Friday, January 1, 2021 | 9736000000 | 104128000 |
| Saturday, January 1, 2022 | 9762000000 | 108630000 |
| Sunday, January 1, 2023 | 10935000000 | 134951000 |
| Monday, January 1, 2024 | 13583000000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. AstraZeneca PLC and Rhythm Pharmaceuticals, Inc. offer a fascinating contrast in their R&D investments over the past decade. From 2014 to 2023, AstraZeneca's R&D expenses have surged by nearly 96%, reflecting a robust commitment to pioneering new treatments. In 2023 alone, AstraZeneca allocated approximately 10.9 billion dollars to R&D, a testament to its strategic focus on innovation.
Conversely, Rhythm Pharmaceuticals, a smaller player, has shown a remarkable growth trajectory in its R&D spending, increasing by over 2,400% from 2014 to 2023. This growth underscores Rhythm's aggressive pursuit of breakthroughs in niche therapeutic areas. While AstraZeneca's R&D budget dwarfs that of Rhythm, the latter's rapid increase highlights its potential to disrupt the market with novel solutions.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and AstraZeneca PLC
Research and Development Expenses Breakdown: AstraZeneca PLC vs Zoetis Inc.
R&D Insights: How AstraZeneca PLC and Bio-Techne Corporation Allocate Funds
AstraZeneca PLC vs Verona Pharma plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for AstraZeneca PLC and HUTCHMED (China) Limited
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Genmab A/S vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds